Patterns and Predictors of Depression Treatment among Older Adults with Parkinson’s Disease and Depression in Ambulatory Care Settings in the United States
Table 1
Demographic and clinical characteristics and depression treatment of older adults with Parkinson disease and depression.
Characteristics
Wt. Freq. (millions)
Wt. %
Predisposing factors
Age
65–74
0.756
44.70
≥75
0.935
55.30
Gender
Male
0.921
54.45
Female
0.770
45.55
Race/ethnicity
White only, NH
1.472
87.03
Others
0.219
12.97
Geo region
West
0.288
17.05
Northeast
0.384
22.72
Midwest
0.197
11.64
South
0.822
48.59
Metro status
Metro
1.337
79.07
Nonmetro
0.354
20.93
Enabling factors
Insurance
Govt. insurance
1.438
85.04
Others
0.253
14.96
Physician/clinic specialty
General and family practice
0.227
13.41
Others
1.464
86.59
Need factors
New prescription during visit
≥1
0.723
42.74
No
0.968
57.26
New patient
Yes
0.217
12.84
No
1.474
87.16
Anti-Parkinson medication
Yes
0.750
44.36
No
0.941
55.64
Chronic diseases
Arthritis
0.411
24.31
Asthma
0.130
7.71
Cancer
0.084
4.97
CHF
0.556
3.29
COPD
0.194
11.49
Diabetes
0.624
36.91
HYPLIPID
0.649
38.36
HTN
0.832
49.17
IHD
0.338
19.96
CEBVD
0.199
11.78
Osteoporosis
0.088
5.19
Overall depression treatment
Depression treatment
0.975
57.63
Note. Based on unweighted (nationally representative weighted million) ambulatory visits of older adults (age ≥ 65 years) with Parkinson’s disease and depression using NAMCS and NHAMCS 2005–2011 data; NAMCS: National Ambulatory Medical Care Survey; NHAMCS: National Hospital Ambulatory Medical Care Survey; Wt: weighted; Freq.: frequency; NH: non-Hispanic; Govt.: government; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; HYPLIPID: hyperlipidemia; HTN: hypertension; IHD: ischemic heart disease; CEBVD: cerebrovascular disease.
